Erika Maclin
Physician Assistant · Murfreesboro, TNNPI 1356867774
Payments from drug & device makers
Across 361 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- Novo Nordisk$871
- Insulet Corporation$526
- AbbVie$480
- Xeris Pharmaceuticals, Inc.$400
- Dexcom, Inc.$376
- plus $3K from 28 others
What the payments were for
- Food & beverage$7,34199%
- Education$661%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 70 | $1,314 |
| Novo Nordisk | 47 | $871 |
| Insulet Corporation | 25 | $526 |
| AbbVie | 23 | $480 |
| Xeris Pharmaceuticals, Inc. | 29 | $400 |
| Dexcom, Inc. | 30 | $376 |
| Sanofi-aventis U.S. LLC | 13 | $348 |
| Amgen | 17 | $341 |
| AstraZeneca(2 entities) | 9 | $297 |
| Cequr Corporation | 3 | $264 |
| Boehringer Ingelheim | 14 | $238 |
| Medtronic | 9 | $237 |
| Abbott | 14 | $233 |
| BETA Bionics, Inc. | 4 | $204 |
| Corcept Therapeutics | 4 | $203 |
| Tandem Diabetes Care, Inc. | 4 | $185 |
| Mannkind Corporation | 8 | $176 |
| Antares Pharma, Inc. | 9 | $160 |
| Bayer | 5 | $97 |
| Sequel Med Tech, LLC | 3 | $84 |
| Ascendis Pharma Endocrinology Inc | 3 | $63 |
| IBSA Pharma Inc. | 3 | $62 |
| Tolmar, Inc. | 4 | $57 |
| Merit Medical Systems Inc | 1 | $25 |
| Astellas Pharma US Inc | 1 | $21 |
| Exeltis, USA Inc. | 1 | $18 |
| Nevro Corp. | 1 | $17 |
| Halozyme Inc | 1 | $17 |
| Amphastar Pharmaceuticals, Inc. | 1 | $16 |
| Novartis | 1 | $16 |
| Millicent US Inc | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Merck | 1 | $14 |
| Radius Health, Inc. | 1 | $14 |
How this compares
$7,406 in reported general payments places this provider in the 90th percentile of 2,404 physician assistant providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 169 | $290,179 |
| MounjaroTirzepatide | 85 | $143,016 |
| JardianceEmpagliflozin | 78 | $105,699 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 65 | $89,999 |
| TrulicityDulaglutide | 55 | $89,588 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 30 | $66,026 |
| Tresiba Flextouch U-200Insulin Degludec | 49 | $65,846 |
| Tresiba Flextouch U-100Insulin Degludec | 56 | $40,705 |
| FarxigaDapagliflozin Propanediol | 35 | $38,389 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 37 | $35,890 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 49 | $29,750 |
| TresibaInsulin Degludec | 18 | $24,921 |
| RybelsusSemaglutide | 19 | $24,360 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 17 | $22,288 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 38 | $19,896 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Tresiba, Rybelsus, Novolog | $871 | $351,193233 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $1,314 | $238,139166 claims |
| Boehringer IngelheimJardiance | $238 | $105,69978 claims |
| AstraZenecaFarxiga | $297 | $38,38935 claims |
| MerckJanuvia | $14 | $14,86612 claims |
| AbbVieSynthroid | $480 | $8,715127 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $15 | $2,712306 claims |
| Sanofi-aventis U.S. LLCLantus | $348 | $2,41912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,404 physician assistant providers in Tennessee.
Other physician assistant in Murfreesboro
- Joseph AyersMurfreesboro$73K
- Ruchi PatelMurfreesboro$23K
- Bailey ChitwoodMurfreesboro$22K
- Taylor NewmanMurfreesboro$16K
- Kurt KnollMurfreesboro$13K
- Lindsey NixKnoxville$576K
- Anna KerseySavannah$399K
- Jason HenryNashville$329K
- Brie ChandlerNashville$317K
- Loree EasleyBartlett$209K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.